trending Market Intelligence /marketintelligence/en/news-insights/trending/xc-dfjzbsj5ipgogxh9zeq2 content esgSubNav
In This List

VBI Vaccines directors resign

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


VBI Vaccines directors resign

VBI Vaccines Inc. said Steven Rubin and Adam Logal resigned as board members, effective Oct. 18.

Their resignations were not due to any disagreement with VBI, the biopharmaceutical company said in a release.

Cambridge, Mass.-based VBI develops and sells vaccines for infectious disease and immuno-oncology in Israel and internationally.